Evaluation of vaginitis and its treatment.

In 30 seconds

This systematic review evaluates the management of vaginitis, a prevalent condition in women. It discusses traditional evaluation and treatment methods, highlights recent randomized controlled trials on partner treatment for bacterial vaginosis and oteseconazole for vulvovaginal candidiasis, and explores future management strategies. The review emphasizes the high recurrence rates of vaginitis.

Key findings

• A randomized controlled trial showed that treating male partners reduced the recurrence rate of bacterial vaginosis.
• Intravaginal vitamin C was investigated for its effectiveness in treating and preventing recurrent bacterial vaginosis.
• Oteseconazole demonstrated benefits against recurrent vulvovaginal candidiasis in a randomized controlled trial.
• A meta-analysis evaluated the impact of vaginal estrogen on breast cancer recurrence and mortality.

Why it matters

Vaginitis is a common issue that can significantly affect women's health and quality of life. Understanding effective treatment options and management strategies is essential for improving patient outcomes and reducing recurrence rates.